The device maker promoted Matt Link to executive VP of U.S sales, according to a press release. Link joined the company in 2006, prior to which he worked at DePuy Orthopedics and then DePuy Spine as a regional sales leader.
NuVasive also promoted Russell Powers to international executive VP. Powers joined NuVasive in 2001 as an executive in a marketing and operations position. Powers previously worked at Medtronic’s (NYSE:MDT) spinal & biologics business.
Thirdly, Scott Durall assumed the position of executive VP of strategic sales & operations. Durall joined the company in 2008 as area sales VP and senior VP of sales operations, prior to which worked at U.S. Surgical Corp. and Boston Scientific (NYSE:BSX).
"The ability to promote internally for these roles is culturally invaluable and I have tremendous confidence in the team we have organized to help us achieve our vision to further change spine surgery now and as a $1 billion start-up," chairman & CEO Alex Lukianov said in prepared remarks. "I look forward to working even more closely with this group of leaders to execute our market share taking strategy both domestically and internationally."
Raanes will receive $475,120.05 and outplacement services, according to the regulatory filing.
Barth leaves a role as an independent corporate financial and strategic planning consultant, prior to which, he worked at Emphusion, NWT/Tandem Labs.
Rotech Health has new CEO
Rotech Healthcare promoted COO Steven Alsene to president & CEO of the company, effective January 1, 2013.
Alsene will succeeds current president & CEO Philip Carter, who in June announced his retirement.
Alsene joined the company in 2003, prior to which, he worked at
Harcourt Education, a division of Reed Elsevier PLC and PricewaterhouseCoopers.
She joined UnitedHealth Group in 2008, prior to which Boudreaux was executive VP of Health Care Services Corporation and president of Blue Cross and Blue Shield of Illinois, a division of HCSC.